Two Sigma Securities »

Enlivex Therapeutics shares owned by Two Sigma Securities

Quarter-by-quarter ownership of Enlivex Therapeutics (ENLV) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in Enlivex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enlivex Therapeutics held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enlivex Therapeutics by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2025-09-30 $36k 34k 1.04
2025-03-31 $28k 28k 0.97
2024-12-31 $26k 22k 1.17

More positions owned by Two Sigma Securities

Ishares Core Msci Emkt (IEMG)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Ishares Tr China Lg-cap Etf (FXI)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr Msci Acwi Etf (ACWI)
Ishares Tr Msci Eafe Etf (EFA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Cme (CME)
Fox Corp Cl A Com (FOXA)
Home Depot (HD)
Ishares Tr Broad Usd High (USHY)
NVIDIA Corporation (NVDA)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Capital One Financial (COF)

View all positions for Two Sigma Securities

Top funds holding Enlivex Therapeutics

Citizens Financial Group
Morgan Stanley
Renaissance Technologies
Citadel Advisors
Susquehanna International
XTX Topco
Two Sigma Securities
Sigma Investment Counselors
Jane Street
Hrt Financial
Prosperity Consulting Group
Neuberger Berman Group
Two Sigma Investments
SkyView Investment Advisors
Wells Fargo & Company

View all funds holding Enlivex Therapeutics